Corbus Pharmaceuticals announces $27.2 million registered direct offering
Corbus announced a Securities Purchase Agreement for the sale of shares of its common stock in a registered direct offering to investors. The Company is selling 3,887,815 shares at a purchase price of $7.00 per share with gross proceeds of $27.2 million and net proceeds of $27.1 million. February 28, 2017